Cargando…

The Effect of the Long-Term Calcipotriol/Betamethasone Dipropionate Local Therapy on Tissue Resident Memory Cells Markers in Psoriatic Eruptions

Background: The natural course of psoriasis is characterized by the long-term persistence of lesions and a predilection for relapse in the same area. It is caused by the inherence of TRM (tissue resident memory T cells) in apparently healthy skin. These cells are able to initiate an inflammatory cas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasprowicz-Furmańczyk, Marta, Czerwińska, Joanna, Placek, Waldemar, Owczarczyk-Saczonek, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319993/ https://www.ncbi.nlm.nih.gov/pubmed/35886201 http://dx.doi.org/10.3390/ijerph19148345

Ejemplares similares

Assessment of the Tissue Resident Memory Cells in Lesional Skin of Patients with Psoriasis and in Healthy Skin of Healthy Volunteers
por: Kasprowicz-Furmańczyk, Marta, et al.
Publicado: (2021)

Immunological Memory of Psoriatic Lesions
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Changes in Tumor Necrosis Factor α (TNFα) and Peptidyl Arginine Deiminase 4 (PAD-4) Levels in Serum of General Treated Psoriatic Patients
por: Czerwińska, Joanna, et al.
Publicado: (2022)

The effect of therapy on TRM in psoriatic lesions
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2022)

Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris
por: Vakirlis, Efstratios, et al.
Publicado: (2008)

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis
por: Anderko, Marian, et al.
Publicado: (2019)

The Role of Chemokines in Psoriasis—An Overview
por: Zdanowska, Natalia, et al.
Publicado: (2021)

Surgical Treatment of Vitiligo
por: Frączek, Alicja, et al.
Publicado: (2022)

Efficacy of calcipotriol plus betamethasone dipropionate foam on psoriatic skin lesions beyond human eyes: An observational study
por: Anna, Campanati, et al.
Publicado: (2022)

Fatigue – an underestimated symptom in psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2017)

Efficacy and Safety of Calcipotriol/Betamethasone Dipropionate Ointment for the Treatment of Trachyonychia: An Open-Label Study
por: Park, Jung-Min, et al.
Publicado: (2015)

Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment
por: Rudnicka, Lidia, et al.
Publicado: (2021)

Editorial: fixed‐dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis
por: Lebwohl, M., et al.
Publicado: (2021)

Sleep disorders in patients with psoriatic arthritis and psoriasis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2018)

Prevalence and severity of fatigue in psoriasis and psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2020)

The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients – preliminary report
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2018)

Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
por: Pinter, Andreas, et al.
Publicado: (2018)

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis
por: Queille-Roussel, Catherine, et al.
Publicado: (2016)

Changes in body composition and bone mineral density in postmenopausal women with psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2017)

Evaluation of selected mechanisms of immune tolerance in psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2019)

Effect of methotrexate treatment on the expression of epidermal-fatty acid-binding protein (E-FABP) and apolipoproteins in patients with psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Patient satisfaction and efficacy of calcipotriol plus betamethasone dipropionate gel in plaque psoriasis patients with poor adherence
por: Takahashi, Hidetoshi, et al.
Publicado: (2020)

Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review
por: Torres, Tiago, et al.
Publicado: (2023)

Ultrasound Assessment of Changes in Nails in Psoriasis and Psoriatic Arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2018)

The Correction of Facial Morphea Lesions by Hyaluronic Acid: A Case Series and Literature Review
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris
por: Kontochristopoulos, George, et al.
Publicado: (2016)

Efficacy of an Innovative Aerosol Foam Formulation of Fixed Combination Calcipotriol plus Betamethasone Dipropionate in Patients with Psoriasis Vulgaris
por: Queille-Roussel, Catherine, et al.
Publicado: (2015)

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam is Effective, Independent of Body Mass Index and the Extent and Severity of Psoriasis
por: Stein Gold, Linda, et al.
Publicado: (2016)

Calcipotriol and betamethasone dipropionate synergistically enhances the balance between regulatory and proinflammatory T cells in a murine psoriasis model
por: Satake, Kyosuke, et al.
Publicado: (2019)

Real-World Experience Using Topical Therapy—Calcipotriol and Betamethasone Dipropionate Foam in Adults with Beyond-Mild Psoriasis
por: Aschoff, Roland, et al.
Publicado: (2021)

Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients
por: Aschoff, Roland, et al.
Publicado: (2021)

Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation
por: Colombo, Giorgio L, et al.
Publicado: (2012)

Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12–17 years of age*
por: Gooderham, M, et al.
Publicado: (2014)

Does molecular scarring in psoriasis exist? A review of the literature
por: Kasprowicz-Furmańczyk, Marta, et al.
Publicado: (2023)

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study
por: Paul, Carle, et al.
Publicado: (2017)

Early efficacy and safety data with fixed‐dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency
por: Tada, Y., et al.
Publicado: (2021)

Cutaneous Eruptions in the Course of COVID-19 Among Geriatric Patients in a Nursing Home in Poland
por: Rybak-d’Obyrn, Joanna, et al.
Publicado: (2022)

Calcipotriol/Betamethasone Dipropionate Foam Inhibits Th17 Cytokine Secretion and Improves Epidermal Barrier Markers in a Human Th17 Skin Inflammation Model
por: Lovato, Paola, et al.
Publicado: (2021)

Kinetics of Thermal Degradation of Betamethasone Valerate and Betamethasone Dipropionate in Different Media
por: Khattak, S. U. R., et al.
Publicado: (2012)

Betamethasone valerate dressing is non-inferior to calcipotriol–betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial
por: Ortonne, J-P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_urcjj5oite00bk4j7rtv0m5ghj